Up a level |
Pope, Daniel ORCID: 0000-0003-2694-5478, Johnson, Michael, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Jagoe, Kirstie, Duarte, Rui, Maden, Michelle ORCID: 0000-0003-4419-6343, Ludolph, Ramona, Bruce, Nigel, Shupler, Matthew ORCID: 0000-0003-0259-9101, Adair-Rohani, Heather et al (show 1 more authors)
(2021)
Are cleaner cooking solutions clean enough? A systematic review and meta-analysis of particulate and carbon monoxide concentrations and exposures.
ENVIRONMENTAL RESEARCH LETTERS, 16 (8).
083002-083002.
Stainthorpe, Angela, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dundar, Yenal, McEntee, Joanne and Syndikus, Isabel
(2020)
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 4 (4).
pp. 563-574.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018)
Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12).
[Report]
Bradley, Peter M, Lindsay, Bruce and Fleeman, Nigel ORCID: 0000-0002-4637-9779
(2016)
Care delivery and self management strategies for adults with epilepsy.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2 (2).
CD006244-.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bradley, Peter M and Lindsay, Bruce
(2015)
Care delivery and self management strategies for children with epilepsy.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015 (12).
CD006245-.
Fleeman, Nigel ORCID: 0000-0002-4637-9779 and Bradley, Peter M
(2018)
Care delivery and self-management strategies for children with epilepsy.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (3).
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bradley, Peter M, Panebianco, Mariangela and Sharma, Anika
(2022)
Care delivery and self-management strategies for children with epilepsy.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 4 (4).
CD006245-.
Fleeman, Nigel ORCID: 0000-0002-4637-9779 and Bradley, Peter M
(2018)
Care delivery and self-management strategies for children with epilepsy.
The Cochrane database of systematic reviews, 3 (3).
CD006245-.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Duarte, Rui, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Dundar, Yenal, McEntee, Joanne and Ahmad, Sajjad
(2019)
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 3 (4).
pp. 453-461.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dickson, Rumona ORCID: 0000-0003-1416-0913, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal, Davis, Helen and Banks, Lindsay
(2015)
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective.
PHARMACOECONOMICS, 33 (9).
pp. 893-904.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, McEntee, Joanne and Thorp, Nicky
(2019)
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 3 (3).
pp. 293-302.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Chaplin, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Mcentee, Joanne and Thorp, Nicky
(2017)
Eribulin for treating locally advanced or metastatic breast cancer after one prior chemotherapy regimen.
[Report]
Puzzolo, Elisa ORCID: 0000-0001-9177-5298, Fleeman, Nigel, Lorenzetti, Federico, Rubinstein, Fernando, Li, Yaojie, Xing, Ran, Shen, Guofeng, Nix, Emily, Maden, Michelle ORCID: 0000-0003-4419-6343, Bresnahan, Rebecca et al (show 6 more authors)
Health Effects from Domestic Use of Gaseous and Liquid Fuels for Cooking and Heating in High, Middle and Low-Income Countries: A Systematic Review and Meta-Analysis.
Nix, Emily ORCID: 0000-0003-3331-2046, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Lorenzetti, Federico, Lewis, Jessica, Shen, Guofeng, Abebe, Lydia, Li, Yaojie, Xing, Ran, Maden, Michelle, Duarte, Rui et al (show 5 more authors)
(2022)
Health effects of liquid and gaseous fuels for household energy use: systematic evidence mapping.
ENVIRONMENTAL RESEARCH LETTERS, 17 (12).
p. 123003.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Dundar, Yenal, Shah, Prakesh S and Shaw, Ben NJ
(2019)
Heated Humidified High-Flow Nasal Cannula for Preterm Infants: An Updated Systematic Review and Meta-analysis.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 35 (4).
pp. 298-306.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui et al (show 1 more authors)
(2020)
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
HEALTH TECHNOLOGY ASSESSMENT, 24 (2).
1-+.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie, Kotas, Eleanor, Banks, Lindsay and Greystoke, Alastair
(2014)
Nintedanib for previously treated locally advanced or metastatic non small cell lung cancer.
[Report]
Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki
(2023)
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
PharmacoEconomics - Open, 7 (6).
pp. 863-875.
Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 3 more authors)
(2023)
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PharmacoEconomics - open, 7 (4).
pp. 525-536.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Abdulla, Ahmed, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty ORCID: 0000-0002-7097-8704, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, McEntee, Joanne and Palmer, Daniel ORCID: 0000-0002-7147-5703
(2018)
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS, 36 (3).
pp. 289-299.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Dickson, Rumona ORCID: 0000-0003-1416-0913, Proudlove, Chris and Dundar, Yenal
(2015)
Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer.
PHARMACOECONOMICS, 33 (1).
pp. 13-23.
Huang, Yun, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Doherty, Alison J, Wilson, Neil, Boland, Paul, Clegg, Andrew, Shaw, Elizabeth J, Nevitt, Sarah J, Tudur Smith, Catrin ORCID: 0000-0003-3051-1445, Hill, Ruaraidh A et al (show 1 more authors)
(2023)
Service delivery, behavioural, and self-management interventions for adults with epilepsy.
Cochrane Database of Systematic Reviews, 2023 (3).
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Panebianco, Mariangela, Hill, Ruaraidh A, Doherty, Alison J, Nevitt, Sarah J, Boland, Paul, Clegg, Andrew, Wilson, Neil, Shaw, Elizabeth J and Marson, Anthony G
(2023)
Service delivery, behavioural, and self-management interventions for children with epilepsy.
Cochrane Database of Systematic Reviews, 2023 (3).
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Abdulla, Ahmed, Kotas, Eleanor, Banks, Lindsay et al (show 1 more authors)
(2017)
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS, 35 (10).
pp. 1035-1046.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Chaplin, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Stainthorpe, Angela, Abdulla, Ahmed, Kotas, Eleanor, Banks, Lindsay et al (show 1 more authors)
(2016)
Talimogene laherparepvec for treating metastatic melanoma.
[Report]
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar et al (show 1 more authors)
(2023)
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 7 (3).
pp. 345-358.
Martin, Antony ORCID: 0000-0003-4383-6038, Downing, Jennifer ORCID: 0000-0001-7691-1167, Maden, Michelle ORCID: 0000-0003-4419-6343, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Haycox, Alan ORCID: 0000-0001-6659-4866 and Pirmohamed, Munir ORCID: 0000-0002-7534-7266
(2017)
An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.
PHARMACOGENOMICS, 18 (16).
pp. 1541-1550.
Nicholson, Amanda, Mahon, James, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Hockenhull, Juliet ORCID: 0000-0002-2026-3778 and Dundar, Yenal
(2015)
The clinical effectiveness and cost-effectiveness of the PROGENSA (R) prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
Health Technology Assessment, 19 (87).
1-+.
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454 and Duarte, Rui
(2021)
A systematic review of health state utility values for thyroid cancer.
QUALITY OF LIFE RESEARCH, 30 (3).
pp. 675-702.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya
(2019)
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine.
BMC CANCER, 19 (1).
1209-.